Keywords
COPD, Pneumonia, urea, creatinine, blood count
COPD, Pneumonia, urea, creatinine, blood count
Pneumonia has been known since late 1800s, and has been recognized as a major cause of death1. Pneumonia is one of the most common causes of mortality in children under 5 years, and common in South Asia and sub-Saharan Africa; it is a form of acute respiratory tract infection2. The annual incidence of community-acquired pneumonia (CAP) ranges from 5 to 11 per 1000 persons in the United States. It is common in the winter. There are several risk factors associated with CAP, such as neurologic and gastrointestinal abnormalities, male gender, multilobar involvement, high fever, etc.3. CAP is an infection of the pulmonary parenchyma by causative microorganisms4. Streptococcus pneumonia is the leading cause of bacterial pneumonia, causing 30-50% of childhood pneumonia in developing countries5. In diagnosis of the disease, chest X-rays, complete blood count and electrolyte count tests are used5. In treatment of pneumonia, medication and antibiotic therapy are commonly used. A 6-month observation is recommended by the UK National Institute for Health and Care Excellence. In addition, it is important to examine environmental conditions as well as given medication or therapy6. It is reported that smoking, chronic lung diseases, heart disease and diabetes increase the prevalence of disease7.
Chronic obstructive pulmonary disease (COPD) is another common lung disease, characterized by a slow and debilitating progression8. It causes changes in the lungs with airflow restrictions and physical symptoms such as dyspnoea9. Obstructive bronchiolitis and emphysema may represent comorbidities of COPD10,11. There is evidence that inhaled corticosteroids, a treatment for COPD, and increase risk of pneumonia12. In addition, previous research has shown that exacerbation of COPD and pneumonia in COPD has different clinical and analytical properties, although mechanisms are similar12,13.
This study aimed to investigate the diagnostic value of urea, creatinine and some blood parameters in patients with pneumonia that had been diagnosed with COPD for the first time.
In this retrospective study, patients who had been diagnosed with COPD for the first time and were diagnosed with Pneumonia and who were admitted to Kadıköy Medicana Hospital, Istanbul, Turkey, between 12 October 2017 and 12 October 2018 were included in the study. A sample of convenience was used, with a voluntary patient consent form. The eligibility criteria were as follows:
— Previously diagnosed with pneumonia,
— First diagnosed with COPD,
— Without a history of clinical intervention in patient epicrisis,
— Without a malignant disorder
— Completed patient consent form
A total of 123 patients with pneumonia among 160 patients who met inclusion criteria were included in the study. A total of 193 patients were divided into three groups as COPD + pneumonia (n = 123), COPD (n = 36) and pneumonia (n = 34). In the second group of patients diagnosed with COPD, the patients who were not diagnosed with pneumonia were designated as the first control group, and patients diagnosed with pneumonia and patients who were not diagnosed with COPD was the second control group. Each patient provided written informed consent for their clinical details to be used when admitted; the hospital management granted approval for this study.
The variables assessed in this study were age, gender, CRP, Urea, Creatine, WBC, NEU, EOS and HGB, which were taken from patient records with approval.
The binary and ordinal data were described by frequency analysis and the other measurement parameters by mean and standard deviation values. Kolmogorov-Smirnov analysis was performed to assess normality distribution of the data before the difference analysis. Independent samples t-test was used for the difference of normal distribution between WBC and hemoglobin data. The Mann-Whitney U-test was used to analyze the difference between paired groups (COPD + pneumonia vs COPD only; COPD + pneumonia vs pneumonia only; COPD only vs pneumonia only) of CRP, urea, creatinine, neutrophils and eosinophils parameters which did not conform to normal distribution. Receiver operating characteristics (ROC) analysis was used for CRP, urea, WBC and NEU. All analyses were performed in SPSS 17.0 for Windows, and performed at 95% confidence interval.
The distribution of gender, age and some clinical parameters of the case groups included in the study are shown in Table 1.
In total, there were 59 women (48.0%) and 64 men (52.0%) in the COPD + pneumonia group, 13 women (36.1%) and 23 men (63.9%) in the COPD group, and 21 women (61.8%) and 13 men (38.2%) in the pneumonia group included in the study. The mean age of patients was 70±14 in the COPD + pneumonia group, 66±13 in the COPD group and 54±20 in the pneumonia group. The highest values of CRP, urea, creatinine, WBC, neutrophils, eosinophils and hemoglobin were observed in the COPD + pneumonia group. The results of the differential analysis of the clinical parameters in the study are presented in Table 2. Raw values are available on Open Science Framework14.
Parameter | Group 1 vs group 2 | Group 1 vs group 3 | Group 2 vs group 3 |
---|---|---|---|
CRPa | 0.006 | 0.536 | 0.117 |
Ureaa | 0.153 | 0.006 | 0.329 |
Creatinea | 0.319 | 0.311 | 0.850 |
WBCb | 0.056 | 0.022 | 0.592 |
NEUa | 0,137 | 0.033 | 0.040 |
EOSa | 0.438 | 0.238 | 0.005 |
HGBb | 0.803 | 0.099 | 0.182 |
According to the results of the difference analysis, there was a statistically significant difference between CRP levels of the COPD + pneumonia and COPD groups (p<0.05). The parameters urea, WBC and neutrophils were significantly different between the COPD + pneumonia and pneumonia groups (p<0.05). There was a statistically significant difference between COPD and pneumonia groups in terms of neutrophils and eosinophils values (p<0.05). The results of ROC analysis of CRP, urea, WBC and neutrophils variables were given as follows.
According to the results of the ROC analysis (Figure 1), the diagnostic value of the urea parameter in determining the COPD + pneumonia group was not statistically significant (p>0.05). On the other hand, the diagnostic value of CRP, WBC and neutrophils values were statistically significant (p<0.05). The distribution of areas under the curve according to ROC analysis is given in Table 3.
The area under the curve was the highest for the CRP value.
Pneumonia15–17 and COPD18–20 are two diseases that are the focus of considerable research into respiratory complaints. In addition, there are studies reporting the distribution of these diseases in different demographic groups21–26. In our study, pneumonia was more common in women, whereas COPD was more common in men. In both groups, the gender distributions were similar, although males made up the majority. However, the mean age of patients was the highest in COPD + pneumonia patients.
In patients with COPD and pneumonia, the clinical condition of the patients is poorer than for patients with one or the other conditions, and it is suggested that two diseases trigger each other25–34. In our study, urea and creatinine levels were higher in patients with pneumonia who were diagnosed with COPD for the first time. WBC and neutrophil values were statistically higher among patients with COPD than in patients with only pneumonia. The difference in urea, WBC and neutrophil values was not significant between the COPD and COPD + pneumonia groups. It can be said that the increase in these three parameters may have diagnostic implications for COPD in patients with pneumonia.
According to the results of this study, a history of pneumonia aggravates the clinical course of patients with COPD for the first time. On the other hand, the increase in CRP, WBC and neutrophil values in patients diagnosed with pneumonia but not COPD may give the first indication of a possible development of COPD.
According to the results of ROC analysis, CRP is among the most important determinants of patients with the first time diagnosed with COPD and diagnosed with pneumonia. On the other hand, WBC and neutrophil elevation in patients with previously diagnosed pneumonia may also be an important factor in the diagnosis of COPD.
Open Science Framework: Diagnostic value of urea, creatinine and blood parameters in patients with pneumonia diagnosed with chronic obstructive pulmonary disease. https://doi.org/10.17605/OSF.IO/Y4V8T14.
This project contains the demographic and clinical variables of patients measured in this study.
Data are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).
The author(s) declared that no grants were involved in funding supporting this work.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the work clearly and accurately presented and does it cite the current literature?
Partly
Is the study design appropriate and is the work technically sound?
Partly
Are sufficient details of methods and analysis provided to allow replication by others?
Partly
If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
Partly
Are the conclusions drawn adequately supported by the results?
Partly
References
1. Mackenzie G: The definition and classification of pneumonia. Pneumonia. 2016; 8 (1). Publisher Full TextCompeting Interests: No competing interests were disclosed.
Is the work clearly and accurately presented and does it cite the current literature?
No
Is the study design appropriate and is the work technically sound?
No
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
No
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
No
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: copd, ıcu, infection
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | ||
---|---|---|
1 | 2 | |
Version 1 05 Apr 19 |
read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)